Protalix BioTherapeutics Inc (PLX)
2.06
-0.03
(-1.44%)
USD |
NYAM |
May 26, 16:00
2.06
0.00 (0.00%)
After-Hours: 20:00
Protalix BioTherapeutics Price: 2.06 for May 26, 2023
Price Chart
Historical Price Data
Date | Open | High | Low | Close | Volume |
---|---|---|---|---|---|
May 26, 2023 | 2.10 | 2.129 | 2.06 | 2.06 | 905203.0 |
May 25, 2023 | 2.28 | 2.29 | 2.09 | 2.09 | 1.523M |
May 24, 2023 | 2.26 | 2.28 | 2.220 | 2.28 | 1.459M |
May 23, 2023 | 2.11 | 2.29 | 2.11 | 2.28 | 2.447M |
May 22, 2023 | 2.05 | 2.16 | 2.01 | 2.12 | 2.247M |
May 19, 2023 | 2.12 | 2.19 | 2.02 | 2.04 | 2.663M |
May 18, 2023 | 2.24 | 2.29 | 2.12 | 2.14 | 4.435M |
May 17, 2023 | 2.16 | 2.37 | 2.14 | 2.36 | 2.822M |
May 16, 2023 | 2.20 | 2.21 | 2.11 | 2.17 | 1.987M |
May 15, 2023 | 2.24 | 2.28 | 2.06 | 2.21 | 5.137M |
May 12, 2023 | 2.55 | 2.60 | 2.16 | 2.23 | 5.336M |
May 11, 2023 | 2.87 | 2.88 | 2.422 | 2.55 | 6.619M |
May 10, 2023 | 3.02 | 3.10 | 2.83 | 2.94 | 7.720M |
May 09, 2023 | 3.07 | 3.13 | 2.715 | 2.92 | 4.050M |
May 08, 2023 | 3.31 | 3.31 | 2.80 | 3.04 | 4.456M |
May 05, 2023 | 3.50 | 3.55 | 3.09 | 3.27 | 3.873M |
May 04, 2023 | 3.13 | 3.36 | 3.03 | 3.36 | 3.487M |
May 03, 2023 | 2.68 | 3.15 | 2.60 | 3.15 | 5.475M |
May 02, 2023 | 2.79 | 2.84 | 2.59 | 2.64 | 3.376M |
May 01, 2023 | 2.82 | 2.94 | 2.66 | 2.90 | 2.754M |
Apr 28, 2023 | 2.73 | 2.80 | 2.51 | 2.78 | 1.937M |
Apr 27, 2023 | 2.74 | 2.75 | 2.55 | 2.67 | 1.850M |
Apr 26, 2023 | 2.51 | 2.78 | 2.47 | 2.70 | 3.190M |
Apr 25, 2023 | 2.42 | 2.545 | 2.40 | 2.49 | 1.150M |
Apr 24, 2023 | 2.41 | 2.42 | 2.37 | 2.41 | 774056.0 |
Price Definition
The price of a security measures the cost to purchase 1 share of a security. For a company, price can be multiplied by shares outstanding to find the market capitalization (value of the company).
Price Range, Past 5 Years
0.81
Minimum
Jan 27 2022
7.52
Maximum
Oct 03 2018
2.886
Average
2.978
Median
Price Benchmarks
Lexicon Pharmaceuticals Inc | 3.18 |
AIM ImmunoTech Inc | 0.4784 |
Perspective Therapeutics Inc | 0.5109 |
Electromed Inc | 12.00 |
Armata Pharmaceuticals Inc | 1.34 |
Price Related Metrics
PS Ratio | 2.572 |
Price to Book Value | 133.69 |
Earnings Yield | -14.56% |
Market Cap | 134.75M |